secwatch.observer — SEC 8-K summary
======================================

Issuer:     Oncotelic Therapeutics, Inc. (OTLC)
CIK:        0000908259
Form:       8-K
Filed at:   2026-08-04T20:15:18+00:00
Accession:  0001493152-26-035999
Event type: debt
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 2.03, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Oncotelic Therapeutics issues $178,410 convertible note to Pacific Pier Capital with 500,000 commitment shares
--------------------------------------------------------------------------------

- Gross principal $178,410; net proceeds ~$150,000 after 12% OID and $7,000 legal fee.
- Note convertible at $0.06/share or 85% of lowest traded price in prior 10 trading days.
- 500,000 commitment shares of common stock issued to Pacific Pier as additional consideration.
- Matures one year from August 3, 2026; 12% interest; 12% original issue discount.
- Prepayment allowed within first six months with three trading days' notice.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/908259/000149315226035999/0001493152-26-035999-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/908259/000149315226035999/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-035999

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer